ENZO BIOCHEM INC (ENZ) Stock Balance Sheet
USA - NYSE:ENZ - US2941001024 - Common Stock
0.3138 USD
-0.07 (-17.77%)
0.32 USD
+0.01 (+1.98%)
| MRQ (2025-1-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 40.30M | 52.37M | 82.37M | 21.60M | 13.52M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | 0 | 29.98M | |||
| Receivables | 4.25M | 3.99M | 4.81M | 4.76M | 10.20M | |||
| Inventories | 5.99M | 6.83M | 7.94M | 9.52M | 12.65M | |||
| Other Current Assets | 1.69M | 6.84M | 3.34M | 6.94M | 4.23M | |||
| Total Current Assets | 52.22M | 70.03M | 98.46M | 42.82M | 70.58M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.87M | 15.20M | 16.71M | 16.02M | 33.60M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | 7.45M | 7.45M | |||
| Intangibles | null | null | null | 0 | 244.00K | |||
| Other Non-Current Assets | 427.00K | 530.00K | 6.71M | 16.77M | 1.81M | |||
| Total Non-Current Assets | 15.29M | 15.73M | 23.42M | 32.79M | 43.11M | |||
| TOTAL ASSETS | 67.51M | 85.76M | 121.88M | 75.61M | 113.69M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 2.51M | 0 | 0 | |||
| Current Portion Of LT Debt. | 73.00K | 76.00K | 75.00K | 229.00K | 233.00K | |||
| Accrued Expenses | 6.21M | 6.55M | 12.72M | 9.07M | 15.04M | |||
| Accounts Payable | 672.00K | 1.38M | 3.58M | 3.71M | 8.12M | |||
| Other Current Liabilities | 10.22M | 16.79M | 21.10M | 0 | 2.67M | |||
| Total Current Liabilities | 17.18M | 24.79M | 39.99M | 13.02M | 26.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 146.00K | 189.00K | 269.00K | 4.08M | 4.47M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 3.57M | 4.67M | 3.16M | 4.05M | 14.56M | |||
| Total Non-Current Liabilities | 3.72M | 4.86M | 3.43M | 8.13M | 19.03M | |||
| TOTAL LIABILITIES | 20.89M | 29.65M | 43.42M | 21.15M | 45.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -299.34M | -294.43M | -268.35M | -288.64M | -270.38M | |||
| Additional Paid In Capital | 343.16M | 348.13M | 344.44M | 339.46M | 337.13M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 523.00K | 521.00K | 499.00K | 487.00K | 485.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 2.27M | 1.89M | 1.88M | 3.15M | 1.35M | |||
| Shares Outstanding | 52.40M | 52.24M | 50.00M | 48.72M | 48.47M | |||
| Tangible Book Value per Share | 0.8896 | 1.074 | 1.5693 | 1.1179 | 1.2562 | |||
| Total Shareholders' Equity | 46.62M | 56.11M | 78.46M | 54.46M | 68.59M | |||
| TOTAL LIABILITIES AND EQUITY | 67.51M | 85.76M | 121.88M | 75.61M | 113.69M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.04 | 0.07 | 0.07 | |||
| Current Ratio | 3.04 | 2.82 | 2.46 | 3.29 | 2.71 | |||
| Return On Assets (ROA) | -31.57% | -30.41% | 16.65% | -24.15% | 6.93% | |||
| Return On Equity (ROE) | -45.72% | -46.47% | 25.86% | -33.53% | 11.48% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 4.89% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 9.71% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | 11.76% | |||
All data in USD , ROIC based on taxRate of 0.21